Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak - ABC News - Breaking News, Latest News and Videos

Moderna has initiated a Phase 1 clinical trial for a new vaccine targeting the specific strain of Ebola responsible for the recent outbreak in the Democratic Republic of the Congo. This trial marks a significant step in the company's efforts to address emerging infectious diseases.